Best Researcher Award
Basant Farag — Faculty of Science, Zagazig University, Egypt
| Basant Farag |
| Affiliation |
Faculty of Science, Zagazig University |
| Country |
Egypt |
| Google Scholar |
PaXwmlgAAAAJ |
| Documents |
60 |
| Citations |
621 |
| h-index |
15 |
| Subject Area |
Chemistry |
| Event |
Botany Scientist Awards |
| Scopus ID |
57464068300 |
| ORCID |
0000-0002-5513-9945 |
Basant Farag is an organic chemistry researcher and university lecturer affiliated with the Faculty of Science, Zagazig University, Egypt. Her academic work focuses primarily on the synthesis and biological evaluation of heterocyclic compounds prepared through diverse synthetic strategies, with particular attention to compounds of potential industrial and pharmacological relevance. Her stated areas of expertise include organic chemistry, synthetic chemistry, heterocyclic chemistry, nanotechnology, green chemistry, biological activities, and computational chemistry.
Farag obtained her M.Sc. and PhD degrees in organic chemistry from Zagazig University and has developed academic experience in teaching, research, scientific peer review, and university activities. Her publication record includes research on heterocyclic systems, molecular docking, mechanochemical synthesis, anticancer-related compounds, and contemporary medicinal chemistry. Selected bibliographic records provide documented examples of these research directions. [1] [2]
Abstract
Basant Farag is an academic researcher in organic chemistry at Zagazig University whose research is centered on the design, synthesis, characterization, and biological evaluation of heterocyclic organic compounds. Her research interests extend to molecular docking and computational chemistry, alongside emerging approaches involving nanotechnology and green chemistry. Published studies include the synthesis and evaluation of heterocyclic compounds with potential biological and pharmacological applications, including investigations involving vascular endothelial growth factor receptor-2 (VEGFR-2) and anticancer-related molecular targets. [3] [4] Her academic profile also includes university teaching and participation in peer review for international scientific journals.[1] [2]
Keywords
Organic chemistry; synthetic chemistry; heterocyclic chemistry; medicinal chemistry; molecular docking; computational chemistry; green chemistry; nanotechnology; biological evaluation; anticancer research; pharmacological applications; chemical synthesis.
Introduction
Basant Farag’s academic career is associated with the Department of Chemistry at the Faculty of Science, Zagazig University. Her research program reflects the interdisciplinary character of contemporary organic and medicinal chemistry, combining chemical synthesis with biological assessment and computational approaches. In particular, her published work addresses the preparation of heterocyclic scaffolds that may serve as candidates for further pharmacological investigation. [3]
The researcher has also undertaken teaching responsibilities in organic chemistry and related chemical sciences. According to the supplied academic record, she has served as a university lecturer since 2024/2025 and previously held assistant lecturer and teaching assistant positions. Her academic activities therefore encompass instruction, research, student support, scientific review, and participation in university-based scholarly activities.
Research Profile
Farag’s research profile is primarily located within organic chemistry, with an emphasis on synthetic methodologies and heterocyclic compound development. Her stated expertise includes organic chemistry, synthesis, heterocyclic chemistry, nanotechnology, green chemistry, biological activities, and computational chemistry. This combination connects classical synthetic chemistry with biological and computational evaluation.
Her academic training includes a Bachelor of Chemistry from Zagazig University, followed by postgraduate degrees in organic chemistry. The supplied record identifies her M.Sc. studies as spanning 2020–2022 and her PhD studies as spanning 2022–2024. Her professional experience includes teaching at university level and participation in scientific peer review for international journals.
Her reported bibliometric indicators include 60 documents, 621 citations, and an h-index of 15 on Google Scholar. The supplied Scopus information reports 49 documents, 570 citations, and an h-index of 15. Bibliometric values can change over time as databases index additional publications and citations, so these figures should be interpreted as profile-specific snapshots rather than permanent measurements. [1] [2]
Research Contributions
The available publication information indicates several interconnected research directions:
- Development and synthesis of novel heterocyclic and related organic compounds using different synthetic routes.
- Biological evaluation of synthesized compounds to investigate their potential pharmacological activities.
- Application of molecular docking and computational chemistry to investigate interactions between synthesized molecules and biologically relevant targets. [3] [4]
- Investigation of mechanochemical approaches to organic synthesis, including the preparation of azine-containing compounds. [4]
- Research into benzimidazole chemistry and its relationship to oncology, including synthesis, biological activity, and structure–activity relationship analysis. [5]
- Academic and scientific service through peer review for international journals in chemistry, medicinal chemistry, pharmaceutical sciences, biology, and related disciplines.
These contributions demonstrate a research approach in which compound synthesis is accompanied by biological and computational assessment. Such integration is common in contemporary medicinal chemistry, where chemical structure, biological activity, and predicted molecular interactions can be examined together.
Publications
Basant Farag’s publications emphasize heterocyclic synthesis, molecular docking, mechanochemical chemistry, and anticancer research, including VEGFR-2-targeting 3-thiazolyl-coumarins, indole-bearing azines, and benzimidazole chemistry in oncology. [3] [4] [5]
The supplied record identifies publications addressing heterocyclic chemistry, molecular docking, mechanochemical synthesis, anticancer research, and medicinal chemistry. The following selected publications illustrate these research themes:
- Farag, B., Fathalla, M., Abolibda, T. Z., Zaki, M. E. A., & Gomha, S. M. (2023). Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase. Molecules, 28(2), 689. [3]
- Ibrahim, M. S., Farag, B., Al-Humaidi, J. Y., Zaki, M. E. A., Fathalla, M., & Gomha, S. M. (2023). Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents. Molecules, 28(9), 3869. [4]
- Farag, B., Zaki, M. E. A., Elsayed, D. A., & Gomha, S. M. (2025). Benzimidazole chemistry in oncology: Recent developments in synthesis, activity, and SAR analysis. RSC Advances, 15(23), 18593–18647. [5]
Research Impact
The supplied bibliometric profile indicates measurable scholarly visibility, with 621 citations and an h-index of 15 reported for Google Scholar, alongside 570 citations and an h-index of 15 reported for Scopus. [1] [2] These indicators provide quantitative evidence of citation activity but should be considered together with publication quality, research originality, disciplinary relevance, collaboration, and broader scholarly contributions.
The selected publications also indicate engagement with research topics of continuing interest in synthetic and medicinal chemistry. Work on thiazolyl-coumarins and VEGFR-2 molecular docking illustrates the use of synthetic chemistry and computational approaches in target-oriented research. [3] Research involving mechanochemical synthesis demonstrates an alternative approach to the preparation of biologically relevant compounds. [4] The 2025 review of benzimidazole chemistry further reflects engagement with the relationship between heterocyclic structure, biological activity, and oncology research. [5]
Beyond publication metrics, the supplied record describes scientific peer-review activity for numerous international journals. This service represents participation in the scholarly evaluation process and complements her teaching and research responsibilities.
Award Suitability
For consideration in the context of the Botany Scientist Awards and the category of Best Researcher Award, the available information documents a research profile centered on chemistry rather than plant science. Her strongest documented areas are organic synthesis, heterocyclic chemistry, biological evaluation, molecular docking, computational chemistry, and medicinally oriented chemical research.
The supplied record provides several factors that may be relevant to an academic recognition assessment, including a sustained university research and teaching role, peer-review service, a reported Google Scholar h-index of 15, a reported Scopus h-index of 15, and publications in international peer-reviewed journals. [1] [2] The selected publications also provide identifiable examples of research outputs in heterocyclic synthesis, molecular docking, mechanochemistry, and oncology-related medicinal chemistry. [3] [4] [5]
Any final award decision should be based on the award’s published eligibility criteria and an independent assessment of the complete scholarly record, including verified publications, citation data, research originality, disciplinary relevance, and documented academic service. The information presented here is therefore a structured academic profile rather than a determination of award outcome.
Conclusion
Basant Farag’s academic profile reflects a developing career in organic chemistry at Zagazig University, supported by postgraduate training, university teaching, research publication, computational investigations, and international peer-review activity. Her principal research contributions concern the synthesis and biological evaluation of heterocyclic compounds, with molecular docking and computational chemistry providing complementary approaches to the investigation of potential biological activity.[1]
The available bibliometric information and selected publications indicate scholarly activity with measurable citation impact.[3][4][5] Her profile is most directly aligned with organic, synthetic, medicinal, and computational chemistry and should be evaluated according to the specific scope and criteria of any academic award for which she is nominated.
External Links
References
- Google Scholar. (n.d.). Google Scholar profile: Basant Farag, profile ID PaXwmlgAAAAJ. Google Scholar. https://scholar.google.com/citations?user=PaXwmlgAAAAJ&hl=en
- Elsevier. (n.d.). Scopus author details: Basant Farag, Author ID 57464068300. Scopus. https://www.scopus.com/pages/authors/57464068300
- Farag, B., Fathalla, M., Abolibda, T. Z., Zaki, M. E. A., & Gomha, S. M. (2023). Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase. Molecules, 28(2), 689. https://doi.org/10.3390/molecules28020689
- Ibrahim, M. S., Farag, B., Al-Humaidi, J. Y., Zaki, M. E. A., Fathalla, M., & Gomha, S. M. (2023). Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents. Molecules, 28(9), 3869. https://doi.org/10.3390/molecules28093869
- Farag, B., Zaki, M. E. A., Elsayed, D. A., & Gomha, S. M. (2025). Benzimidazole chemistry in oncology: Recent developments in synthesis, activity, and SAR analysis. RSC Advances, 15(23), 18593–18647. https://doi.org/10.1039/D5RA01077B